Sanofi announces that Dr. John Reed, head of worldwide research and development (R&D), will be leaving the company to pursue an opportunity outside Sanofi. As a reminder, he had joined the French healthcare giant in 2018.

The group adds that it has begun the internal and external search process for John Reed's succession, stating that Dr. Dietmar Berger has agreed to act as interim head of the R&D organization.

Dr. Berger has been global head of development and chief medical officer since joining Sanofi in 2019, following a career at various pharmaceutical companies, including Genentech, Bayer and Amgen.

Copyright (c) 2023 CercleFinance.com. All rights reserved.